1 in 4 persons is expected to develop heart failure. 46% of cases are due to Diastolic HF. The Center at KFUPM focuses on advancing healthcare technology to enhance ventricular assist devices (VADs) for treating advanced heart failure.
It can potentially enhance life expectancy and quality of life and reduce the overall demand for transplants. This technology uses advanced AI algorithms to continually monitor and analyze real-time physiological data, such as heart rate, blood pressure, and cardiac output which allows the AI to dynamically adjust the VAD's pumping speed to synchronize with the patient's current cardiac status.
The Center has developed its first medical device called PulseVAD. This offers a unique opportunity to revolutionize cardiac support systems and drive transformative change in patient care, making it a novel project in the Kingdom and setting the stage for further medical device innovation. The pump has been developed, tested and patented by international collaborator: Northern Research, Norway.
KFUPM team contributes by innovating the design of the intelligent controller, smart lead and system integration.
Sustainable Development Goals: